LSTM Home > LSTM Research > LSTM Online Archive

Wolbachia-carrying Aedes mosquitoes for preventing dengue infection.

Tools

Fox, Tilly, Sguassero, Yanina, Chaplin, Martha, Rose, Winsley, Doum, Dyna, Arevalo-Rodriguez, Ingrid and Villanueva, Gemma (2024) 'Wolbachia-carrying Aedes mosquitoes for preventing dengue infection.'. Cochrane Database of Systematic Reviews, Vol 4, CD015636.

Preview

Text
Fox_et_al-2024-Cochrane_Database_of_Systematic_Reviews.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.
Download (431kB) | Preview

Official URL: https://doi.org/10.1002/14651858.CD015636.pub2

Abstract

Background
Dengue is a global health problem of high significance, with 3.9 billion people at risk of infection. The geographic expansion of dengue virus (DENV) infection has resulted in increased frequency and severity of the disease, and the number of deaths has increased in recent years. Wolbachia, an intracellular bacterial endosymbiont, has been under investigation for several years as a novel dengue‐control strategy. Some dengue vectors (Aedes mosquitoes) can be transinfected with specific strains of Wolbachia, which decreases their fitness (ability to survive and mate) and their ability to reproduce, inhibiting the replication of dengue. Both laboratory and field studies have demonstrated the potential effect of Wolbachia deployments on reducing dengue transmission, and modelling studies have suggested that this may be a self‐sustaining strategy for dengue prevention, although long‐term effects are yet to be elucidated.

Objectives
To assess the efficacy of Wolbachia‐carrying Aedes species deployments (specifically wMel‐, wMelPop‐, and wAlbB‐ strains of Wolbachia) for preventing dengue virus infection.

Search methods
We searched CENTRAL, MEDLINE, Embase, four other databases, and two trial registries up to 24 January 2024.

Selection criteria
Randomized controlled trials (RCTs), including cluster‐randomized controlled trials (cRCTs), conducted in dengue endemic or epidemic‐prone settings were eligible.

We sought studies that investigated the impact of Wolbachia‐carrying Aedes deployments on epidemiological or entomological dengue‐related outcomes, utilizing either the population replacement or population suppression strategy.

Data collection and analysis
Two review authors independently selected eligible studies, extracted data, and assessed the risk of bias using the Cochrane RoB 2 tool. We used odds ratios (OR) with the corresponding 95% confidence intervals (CI) as the effect measure for dichotomous outcomes. For count/rate outcomes, we planned to use the rate ratio with 95% CI as the effect measure. We used adjusted measures of effect for cRCTs. We assessed the certainty of evidence using GRADE.

Main results
One completed cRCT met our inclusion criteria, and we identified two further ongoing cRCTs. The included trial was conducted in an urban setting in Yogyakarta, Indonesia. It utilized a nested test‐negative study design, whereby all participants aged three to 45 years who presented at healthcare centres with a fever were enrolled in the study provided they had resided in the study area for the previous 10 nights.

The trial showed that wMel‐Wolbachia infected Ae aegypti deployments probably reduce the odds of contracting virologically confirmed dengue by 77% (OR 0.23, 95% CI 0.15 to 0.35; 1 trial, 6306 participants; moderate‐certainty evidence). The cluster‐level prevalence of wMel Wolbachia‐carrying mosquitoes remained high over two years in the intervention arm of the trial, reported as 95.8% (interquartile range 91.5 to 97.8) across 27 months in clusters receiving wMel‐Wolbachia Ae aegypti deployments, but there were no reliable comparative data for this outcome.

Other primary outcomes were the incidence of virologically confirmed dengue, the prevalence of dengue ribonucleic acid in the mosquito population, and mosquito density, but there were no data for these outcomes. Additionally, there were no data on adverse events.

Authors' conclusions
The included trial demonstrates the potential significant impact of wMel‐Wolbachia‐carrying Ae aegypti mosquitoes on preventing dengue infection in an endemic setting, and supports evidence reported in non‐randomized and uncontrolled studies. Further trials across a greater diversity of settings are required to confirm whether these findings apply to other locations and country settings, and greater reporting of acceptability and cost are important.

Item Type:

Article

Subjects:

QX Parasitology > QX 20 Research (General)
QX Parasitology > Insects. Other Parasites > QX 510 Mosquitoes
QX Parasitology > Insects. Other Parasites > QX 525 Aedes
WC Communicable Diseases > Virus Diseases > Infectious Mononucleosis. Arbovirus Infections > WC 528 Dengue

Repository link: